Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Addiction Reports
Erschienen in: Current Addiction Reports 2/2014

01.06.2014 | Stimulants, Cannabis, and Club Drugs (AJ Budney, R Vandrey and D Lee, Section Editors)

Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults

verfasst von: Krista M. Lisdahl, Natasha E. Wright, Christopher Medina-Kirchner, Kristin E. Maple, Skyler Shollenbarger

Erschienen in: Current Addiction Reports | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Thirty-six percent of high-school seniors have used cannabis in the past year, and an alarming 6.5 % smoked cannabis daily, up from 2.4 % in 1993. Adolescents and emerging adults are undergoing significant neurodevelopment and animal studies suggest they may be particularly vulnerable to negative drug effects. In this review, we will provide a detailed overview of studies outlining the effects of regular (at least weekly) cannabis use on neurocognition, including studies outlining cognitive, structural, and functional findings. We will also explore the public health impact of this research.
Literatur
1.
Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: overview of key findings, 2012. Ann Arbor: Institute for Social Research, The University of Michigan; 2013. 83pp.
2.
Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7):e141.
3.
Giedd JN, Vaituzis AC, Hamburger SD, Lange N, Rajapakse JC, Kaysen D, et al. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comp Neurol. 1996;366:223–30.PubMedCrossRef
4.
Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004;101(21):8174–9.PubMedCentralPubMedCrossRef
5.
Lenroot RK, Giedd JN. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. NeurosciBiobehav Rev. 2006;30:718–29.
6.
Sowell ER, Thompson P, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci. 2004;24(38):8223–31.PubMedCrossRef
7.
Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999;2:861–3.PubMedCrossRef
8.
Jernigan T, Gamst A. Changes in volume with age: consistency and interpretation of observed effects. Neurobiol Aging. 2005;26(9):1271–4.PubMedCrossRef
9.
Spear LP. The behavioral neuroscience of adolescence. Neurosci Biobehav Rev. 2010;24:417–63.CrossRef
10.•
Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 2013;4(53):1–19. Earlier review article by current author outlining effects of both alcohol and cannabis on the adolescent brain with particular focus on early age of onset.
11.•
Tapert SF, Granholm E, Leedy NG, Brown SA. Substance use and withdrawal: neuropsychological functioning over 8 years in youth. J Int Neuropsychol Soc. 2002;8(7):873–83. Longitudinal study examining the specific impact of cannabis use on cognition over an 8-year period.PubMedCrossRef
12.•
Tait RJ, Mackinnon A, Christensen H. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction. 2011;106(12):2195–203. Longitudinal study examining the specific impact of cannabis use on cognition over an 8-year period.PubMedCrossRef
13.••
Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):2657–64. Largest prospective, longitudinal study examining impact of cananbis use on IQ and cognition.CrossRef
14.
Takagi M, Lubman DI, Cotton S, Fornito A, Baliz Y, Tucker A, et al. Executive control among adolescent inhalant and cannabis users. Drug Alcohol Rev. 2011;30:620–37.CrossRef
15.••
Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicol Teratol. 2005;27(2):231–9. An important longitudinal study examining the impact of cannabis on cognition over time.PubMedCrossRef
16.•
Gruber SA, Dahlgren MK, Sagar KA, Gönenc A, Killgore WD. Age of onset of marijuana use impacts inhibitory processing. Neurosci Lett. 2012;511(2):89–94. A well designed study examining the impact of early onset cannabis use on neurocognitive functioning, focused on inhibitory control.PubMedCentralPubMedCrossRef
17.
Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas SE. Age of onset of marijuana use and executive function. Psychol Addict Behav. 2012;26(3):486–506.
18.•
Lisdahl KM, Price JS. Increased marijuana use and gender predict poorer cognitive functioning in healthy emerging adults. J Int Neuropsychol Soc. 2012;18(4):678–88. Well designed study fully replicating neuropsychological findings from Medina et al., 2007 in different sample.PubMedCentralPubMedCrossRef
19.••
Medina KL, Hanson K, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after 30 days of abstinence. J Intern Neuropsychol Soc. 2007;13(5):807–20. One of the only studies to assess neuropsychological functioning following a closely monitored month of abstinence in adolescents with medium to heavy cannabis exposure.CrossRef
20.••
Hanson KL, Winward JL, Schweinsburg AD, Medina KL, Brown SA, Tapert SF. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav. 2010;35(11):970–6. A well designed study examining cognitive functioning over a 3-week period of closely monitored abstinence.PubMedCentralPubMedCrossRef
21.
Harvey MA, Sellman JD, Porter RJ, Frampton CM. The relationship between non-acute adolescent marijuana use and cognition. Drug Alcohol Rev. 2007;26(3):309–19.PubMedCrossRef
22.
Mathias CW, Blumenthal TD, Dawes MA, Liguori A, Richard DM, Bray B, et al. Failure to sustain prepulse inhibition in adolescent marijuana users. Drug Alcohol Depend. 2011;116(1–3):110–6.PubMedCentralPubMedCrossRef
23.
McHale S, Hunt N. Executive function deficits in short-term abstinent cannabis users. Hum Psychopharmacol. 2008;23(5):409–15.PubMedCrossRef
24.
Schwartz RH, Gruenewald PJ, Klitzner M, Fedio P. Short-term memory impairment in cannabis-dependent adolescents. Am J Dis Child. 1989;143(10):1214–9.PubMed
25.
Solowij N, Jones KA, Rozman ME, Davis SM, Ciarrochi J, Heaven PC, et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacol (Berl). 2011;216(1):131–44.CrossRef
26.
Thoma RJ, Monnig MA, Lysne PA, Ruhl DA, Pommy JA, Bogenschutz M, et al. Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance. Alcohol Clin Exp Res. 2011;35(1):39–46.
27.
Hanson KL, Medina KL, Nagel BJ, Spadoni AD, Gorlick A, Tapert SF. Hippocampal volumes in adolescents with and without a family history of alcoholism. Am J Drug Alcohol Abuse. 2010;36:161–7.PubMedCentralPubMedCrossRef
28.•
Gonzalez R, Schuster RM, Mermelstein RJ, Vassileva J, Martin EM, Diviak KR. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsychol. 2012;34(9):962–76. A novel study linking cognitive functioning to cannabis use disorder symptoms in youth.PubMedCentralPubMedCrossRef
29.
Grant JE, Chamberlain SR, Schreiber L, Odlaug BL. Neuropsychological deficits associated with cannabis use in young adults. Drug Alcohol Depend. 2012;121(1–2):159–62.PubMedCentralPubMedCrossRef
30.
Schuster RM, Crane NA, Mermelstein R, Gonzalez R. The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users. J Int Neuropsychol Soc. 2012;18(5):827–33.PubMedCentralPubMedCrossRef
31.
Solowij N, Jones KA, Rozman ME, Davis SM, Ciarrochi J, Heaven PC, et al. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology (Berl). 2012;219(2):575–86.CrossRef
32.
Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal asymmetry. NeurotoxicolTeratol. 2007;29:141–52.
33.
Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang T, Tapert SF. Prefrontal morphometry in abstinent adolescent marijuana users: Subtle gender effects. Addict Biol. 2009;14(4):457–68.PubMedCentralPubMedCrossRef
34.
Medina KL, Nagel BJ, Tapert SF. Cerebellar vermis abnormality in adolescent marijuana users. Psychiatr Res Neuroimage. 2010;182(2):152–9.CrossRef
35.
McQueeny TM, Padula C, Price J, Medina KL, Logan P, Tapert SF. Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res. 2011;224(1):128–34.PubMedCentralPubMedCrossRef
36.
Churchwell JC, Carey PD, Ferrett HL, Stein DJ, Yurgelun-Todd DA. Abnormal striatal circuitry and intensified novelty seeking among adolescents that abuse methamphetamine and cannabis. Dev Neurosci. 2012;34(4):310–7.PubMedCentralPubMedCrossRef
37.
Churchwell JC, Lopez-Larson M, Yurgelun-Todd DA. Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol. 2010;1:225.PubMedCentralPubMedCrossRef
38.
Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, Cook P, et al. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res. 2011;45(8):1055–66.PubMedCentralPubMedCrossRef
39.•
Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE. Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. NeuroImage. 2012;59:3845–51. A well designed study examining impact of heavy cannabis use on cortical and subcortical brain structure in chronic cannabis users.PubMedCrossRef
40.
Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012;37(11):2368–76.
41.•
Lopez-Larson MP, Bogorodzki P, Rogowska J, McGlade E, King JB, Terry J, et al. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res. 2011;220(1):164–72. In combination with Lopez-Larson (2012), a very thorough evaluation of how cannabis impacts brain structure in youth.PubMedCentralPubMedCrossRef
42.
Van Essen DC, Drury HA. Structural and functional analyses of human cerebral cortex using a surface-based atlas. J Neurosci. 1997;17(18):7079–102.
43.•
Mata I, Perez-Iglesias R, Roiz-Santiañez R, Tordesillas-Gutierrez D, Pazos A, Gutierrez A. et. al. (2010). Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res. 1317297-304. doi:10.1016/j.brainres.2009.12.069. Novel study examining gyrification, reflecting cortical gray matter complexity, in cannabis users.
44.
Moldrich G, Wenger T. Localization of the CB(1) cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides. 2000;21:1735–42.PubMedCrossRef
45.
Medina KL, Nagel BJ, McQueeny T, Park A, Tapert SF. Depressive symptoms in adolescents: associations with white matter volume and marijuana use. J Child Psychol Psychiatr. 2007;48(6):592–600.CrossRef
46.
Arnone D, Barrick TR, Chengappa S, Mackay CE, Clark CA, Abou-Saleh MT. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. NeuroImage. 2008;41(3):1067–74.PubMedCrossRef
47.
Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res. 2009;43(3):189–204.PubMedCentralPubMedCrossRef
48.
Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF. Altered white matter microstructure in adolescent substance users. Psychiatr Res. 2009;173(3):228–37.CrossRef
49.••
Bava S, Jacobus J, Thayer RE, Tapert SF. Longitudinal changes in white matter integrity among adolescent substance users. Alcohol Clin Exp Res. 2013;37(1):181–9. Unique longitudinal study examining impact of cannabis and alcohol use over 18-month follow-up.CrossRef
50.
DeLisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K, Bappal A, et al. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct J. 2006;3:17.PubMedCentralPubMedCrossRef
51.•
Gruber SA, Dahlgren MK, Sagar KA, Gonenc A, Lukas SE. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology. 2013. doi:10.​1007/​s00213-013-3326-z. Combined with Gruber et al. (2012), a well designed study that measures the impact of early onset cannabis use on white matter integrity and cognitive inhibition.PubMedCentralPubMed
52.
Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D. Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol. 2011;19(3):231–42.PubMedCentralPubMedCrossRef
53.
Clark DB, Chung T, Thatcher DL, Pajtek S, Long EC. Psychological dysregulation, white matter disorganization and substance use disorders in adolescences. Addiction. 2012;7(1):206–14.CrossRef
54.
Jacobus J, Goldenberg D, Wierenga CE, Tolentino NJ, Liu TT, Tapert SF. Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. Psychopharmacology (Berl). 2012;222(4):675–84.CrossRef
55.•
Prescot AP, Locatelli AE, Renshaw PF, Yurgelun-Todd DA. Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage. 2011;57(1)):69–75. A rare study examining the impact of adolescent cannabis use on neuronal health utilizing MRS.PubMedCentralPubMedCrossRef
56.
Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. PsychiatrRes. 2011;191(3):201–11.
57.•
Lopez-Larson MP, Rogowska J, Bogorodzki P, Bueler CE, McGlade EC, Yurgelun-Todd DA. Cortico-cerebellar abnormalities in adolescents with heavy marijuana use. Psychiatr Res. 2012;202(3):224–32. One of the most detailed evaluations of brain structural abnormalities in young cannabis users to date.CrossRef
58.
Abdullaev Y, Posner MI, Nunnally R, Dishion TJ. Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav Brain Res. 2010;215(1):45–57.PubMedCrossRef
59.
Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychia Res. 2008;163(1):40–51.CrossRef
60.•
Schweinsburg AD, Schweinsburg BC, Medina KL, McQueeny T, Brown SA, Tapert SF. The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychol Drugs. 2010;42(3):401–12. One of a few studies to address effects of abstinence on brain function in cannabis using adolescents.CrossRef
61.
Smith AM, Longo CA, Fried PA, Hogan MJ, Cameron I. Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacol (Berl). 2010;210(3):429–38.CrossRef
62.
Jacobsen LK, Pugh KR, Constable RT, Westerveld M, Mencl WE. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent marijuana users. Biol Psychiatr. 2007;61(1):31–40.CrossRef
63.•
Jager G, Block RI, Luijten M, Ramsey NF. Cannabis use and memory brain function in adolescent boys: A cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry. 2010;49(6):561–72. A well designed multi-site study examining brain function in young male cannabis users.PubMedCentralPubMed
64.
Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J. The impact of early-onset cannabis use on functional brain correlates of working memory. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):837–45.PubMedCrossRef
65.
Becker B, Wagner D, Gouzoulis-Mayfrank E, Spuentrup E, Daumann J. Altered parahippocampal functioning in cannabis users is related to the frequency of use. Psychopharmacology. 2010;209(4):361–74.PubMedCrossRef
66.
Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, et al. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berlin). 2007;194:173–83.CrossRef
67.
Vaidya JG, Block RI, O'Leary DS, Ponto LB, Ghoneim MM, Bechara A. Effects of chronic marijuana use on brain activity during monetary decision-making. Neuropsychopharmacology. 2012;37(3):618–29.PubMedCentralPubMedCrossRef
68.
Migliorini R, Stewart JL, May AC, Taper SF, Paulus MP. What do you feel? Adolescent drug and alcohol users show altered brain response to pleasant interoceptive stimuli. DrugAlcohol Depend. 2013;133:661–8.CrossRef
69.•
Behan B, Connolly CG, Datwani MC, Ivanovic J, Morioka R, Stone A, et al. Response inhibition and elevated parietal-cerebellar correlations in chronic adolescent cannabis users. Neuropharmacology. 2013;2908(13):241–4. One of the first studies to utilize functional connectivity analysis in adolescent cannabis users.
70.•
Orr C, Morioka R, Behan B, Datwani S, Doucet M, Ivanovic J, et al. Altered resting-state connectivity in adolescent cannabis users. Am J Drug Alcohol Abuse. 2013;39(6):372–81. A novel study examining resting state functional connectivity in young cannabis users.PubMedCrossRef
71.•
Houck JM, Bryan AD, Feldstein Ewing SW. Functional connectivity and cannabis use in high-risk adolescents. Am J Drug Alcohol Abuse. 2013;39(6):414–23. A novel study examining functional brain connectivity in young cannabis users.PubMedCrossRef
72.•
Harding IH, Solowij N, Harrison BJ, Takagi M, Lorenzetti V, Lubman DI, et al. Functional connectivity in brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology. 2012;37(8):1923–33. A novel study examining functional brain connectivity in young cannabis users.PubMedCentralPubMedCrossRef
73.•
López-Moreno JA, Echeverry-Alzate V, Bühler KM. The genetic basis of the endocannabinoid system and drug addiction in humans. J Psychopharmacol. 2012;26(1):133–43. The most up-to-date review on genetics, the endocannabinoid system and addiction in humans.PubMedCrossRef
74.
Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology. 2010;35(4):967–75.
75.
Bidwell LL, Metrik J, McGeary J, Palmer RC, Francazio SS, Knopik VS. Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems. J Stud Alcohol Drugs. 2013;74(6):867–78.PubMed
76.
Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 ( CNR1) and fatty acid amide hydrolase ( FAAH) genes. Addiction. 2008;103(10):1678–86.PubMedCentralPubMedCrossRef
77.
Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology Berl. 2009;203(3):511–7.PubMedCentralPubMedCrossRef
78.
Rubino T, Zamberletti E, Parolaro D. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. J Psychopharmacol. 2012;26(1):177–88.PubMedCrossRef
79.
Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009;19(8):763–72.PubMedCrossRef
80.
Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS. Differential effects of delta(9)-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav. 2006;83(3):448–55.PubMedCrossRef
81.
Rubino T, Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Mol Cell Endocrinol. 2008;286(1-2 Suppl 1):S108–13.PubMedCrossRef
82.
Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, et al. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008;33:2760–71.PubMedCrossRef
83.
Schneider M, Koch M. Chronic pubertal but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory and performance in a progressive ratio task in adult rats. Neuropsychopharmacology. 2003;28:1760–90.PubMedCrossRef
84.••
Pope Jr H, Gruber A, Hudson J, Cohane G, Huestis M, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003;69(3):303. One of the first papers to address the issue of early cannabis age of onset on neurocognition.PubMedCrossRef
85.
Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. Specific attentional dysfunction in adults following early start of marijuana use. Psychopharmacology. 1999;142(3):295–301.PubMedCrossRef
86.
Huestegge L, Radach R, Kunert HJ, Heller D. Visual search in long-term cannabis users with early age of onset. Prog Brain Res. 2002;140:377–94.PubMedCrossRef
87.•
Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranjeira RR, et al. Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatr. 2011;198(6):442–7. A well designed study closely evaluating the impact of early onset cannabis use on executive functioning.CrossRef
88.•
Tamm L, Epstein JN, Lisdahl KM, Molina B, Tapert S, Hinshaw SP, et al. Impact of ADHD and cannabis use on executive functioning in young adults. Drug Alcohol Depend. 2013;133(2):607–14. One of the only studies to specifically examine combined effects of ADHD and cannabis use on cognitive functioning in emerging adults. This is an important area of research as the effects of cannabis on the brain can mimic symptoms of ADHD (e.g., poor cognitive inhibition, reduced new learning, poorer sustained attention) and individuals with ADHD have an earlier age of cannabis use onset.PubMedCrossRef
89.
Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis. 2000;19(1):1–22.PubMedCrossRef
90.•
Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, et al. Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Drug Alcohol Depend. 2011;114(2/3):242–5. One of the first studies in human users to examine impact of THC versus CBD effects on the brain.PubMed
91.•
Cousijn J, Goudriaan AE, Ridderinkhof KR, wan den Brink W, Veltman DJ, Wiers RW. Approach-bias predicts development of cannabis problem severity in heavy cannabis users: Results from a prospective FMRI study. PLoS One. 2012;7(9):42394. A novel study examining how brain function relates to cannabis problems in young users.CrossRef
92.•
De Bellis MD, Wang L, Bergman SR, Yaxley RH, Hooper SR, Huetel SA. Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder. Drug Alcohol Depend. 2013;133:134–45. An important study examining decision-making brain response in young cannabis users.PubMedCrossRef
93.••
Feldstein Ewing SW, McEachern AD, Yezhuvath U, Bryan AD, Hutchison KE, Filbey FM. Integrating brain and behavior: evaluating adolescents’ response to a cannabis intervention. Psychol Addict Behav. 2013;27(2):510–25. A novel study utilizing fMRI to evaluate effects of behavioral intervention on brain function in adolescent cannabis users.PubMedCrossRef
94.
Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, et al. Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry. 2012;71(8):677–83.PubMedCentralPubMedCrossRef
95.
Hirvonen J, Goodwin R, Li C, Terry G, Zoghbi S, Morse C, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012;17(6):642–9.PubMedCentralPubMedCrossRef
96.
National Institute on Drug Abuse. NIDA DrugFacts: marijuana. Washington: National Institute on Drug Abuse, U.S. Department of Health and Human Services; 2012.
97.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (August 13, 2013). The TEDS Report: Marijuana Admissions Aged 18 to 30: Early vs. Adult Initiation. Rockville, MD.
98.
99.
Niesink RM, van Laar MW, Cannizzaro C, Janiri L. Does cannabidiol protect against adverse psychological effects of THC? Front In Psychiatry. 2013;4:130.CrossRef
100.
Fusar-Poli P (2009). S39-01 Distinct effects of D9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Euro Psychia. 24.
101.
Winton-Brown TT, Allen P, Bhattacharyya S, Borgwardt SJ, Fusar-Poli P, Crippa JA, et al. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology. 2011;36(7):1340–8.PubMedCentralPubMedCrossRef
102.
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35(3):764–74.
103.
Englund A, Morrison P, Nottage J, Hague D, Kane F, Bonaccorso S, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. J Psychopharmacol. 2013;27(1):19–27.PubMedCrossRef
104.
Morgan CJ, Schafer G, Freeman TP, Curran HV. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. Br J Psychiatry. 2010;197(4):285–90.
105.
Morgan CJ, Gardener C, Schafer G, Swan S, Demarchi C, Freeman TP, et al. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol Med. 2012;42(2):391–400.PubMedCrossRef
106.
Hill SY, Kostelnik B, Holmes B, Goradia D, McDermott M, Diwadkar V, et al. fMRI BOLD response to the eyes task in offspring from multiplex alcohol dependence families. Alcoholism Clin Exp Res. 2007;31(12):2028–35.CrossRef
107.
Nigg JT, Glass JM, Wong MM, Poon E, Jester JM, Fitzgerald HE, et al. Neuropsychological executive functioning in children at elevated risk for alcoholism: findings in early adolescence. J Abnorm Psychol. 2004;113(2):302–14.
108.
Ridenour TA, Tarter RE, Reynolds M, Mezzich A, Kirisci L, Vanyukov M. Neurobehavior disinhibition, parental substance use disorder, neighborhood quality and development of cannabis use disorder in boys. Drug Alcohol Depend. 2009;102(1–3):71–7.PubMedCentralPubMedCrossRef
109.
Schweinsburg AD, Paulus MP, Barlett VC, Killeen LA, Caldwell LC, Pulido C, et al. An FMRI study of response inhibition in youths with a family history of alcoholism. Ann New York Acad Sci. 2004;1021:391–4.CrossRef
110.
Spadoni AD, Norman AL, Schweinsburg AD, Tapert SF. Effects of family history of alcohol use disorders on spatial working memory BOLD response in adolescents. Alcohol Clin Exp Res. 2008;32(7):1135–45.PubMedCentralPubMedCrossRef
111.
Tapert SF, Brown SA. Substance dependence, family history of alcohol dependence, and neuropsychological functioning in adolescence. Addiction. 2000;95:1043–53.PubMedCrossRef
112.•
Cheetham A, Allen NB, Whittle S, Simmons JG, Yücel M, Lubman DI. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol Psychiatry. 2012;71(8):684–92. A well designed prospective longitudinal study examining neurocognitive predictors of cannabis initiation.PubMedCrossRef
113.
Raphael D. Adolescence as a gateway to adult health outcomes. Maturitas. 2013;75(2):137–41.PubMedCrossRef
114.
Caulkins JP, Kilmer B, MacCoun RJ, Pacula RL, Reuter P. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19. Addiction. 2012;107(5):865–71.PubMedCrossRef
Metadaten
Titel
Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults
verfasst von
Krista M. Lisdahl
Natasha E. Wright
Christopher Medina-Kirchner
Kristin E. Maple
Skyler Shollenbarger
Publikationsdatum
01.06.2014
Verlag
Springer International Publishing
Erschienen in
Current Addiction Reports / Ausgabe 2/2014
Elektronische ISSN: 2196-2952
DOI
https://doi.org/10.1007/s40429-014-0019-6

Weitere Artikel der Ausgabe 2/2014

Current Addiction Reports 2/2014 Zur Ausgabe

Behavioral Addictions (A Gearhardt, Section Editor)

If Certain Foods are Addictive, How Might this Change the Treatment of Compulsive Overeating and Obesity?

Behavioral Addictions (A Gearhardt, Section Editor)

The Impact of ‘Food Addiction’ on Food Policy

Stimulants, Cannabis, and Club Drugs (AJ Budney, R Vandrey and D Lee, Section Editors)

Impact of Cannabis Use on the Development of Psychotic Disorders

Stimulants, Cannabis, and Club Drugs (AJ Budney, R Vandrey and D Lee, Section Editors)

Sleep Disturbances: Implications for Cannabis Use, Cannabis Use Cessation, and Cannabis Use Treatment

Behavioral Addictions (A Gearhardt, Section Editor)

The Role of Addictive Behaviors in Childhood Obesity

Behavioral Addictions (A Gearhardt, Section Editor)

Potential Role of Addiction Pharmacotherapy in Problematic Eating Behavior

Neu im Fachgebiet Psychiatrie

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise